These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 19902268)

  • 1. Resolution of chyloperitoneum in a preterm with octreotide, diet and cessation of dialysis.
    Soylu A; Alaygut D; Yeşilirmak D; Kasap B; Türkmen M; Duman N; Kavukçu S
    Pediatr Nephrol; 2010 Feb; 25(2):363-6. PubMed ID: 19902268
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recurrent chyloperitoneum: a rare complication of peritoneal dialysis.
    Kumar J; Gordillo R; Del Rio M; Flynn JT
    Pediatr Nephrol; 2008 Apr; 23(4):671-4. PubMed ID: 18095006
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of Propranolol in the Treatment of Chylous Effusions in Infants.
    Mitchell K; Weiner A; Ramsay P; Sahni M
    Pediatrics; 2021 Jul; 148(1):. PubMed ID: 34187907
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Octreotide therapy: a new horizon in treatment of iatrogenic chyloperitoneum.
    Bhatia C; Pratap U; Slavik Z
    Arch Dis Child; 2001 Sep; 85(3):234-5. PubMed ID: 11517107
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chyloperitoneum in a peritoneal dialysis patient.
    Levy RI; Wenk RE
    Am J Kidney Dis; 2001 Sep; 38(3):E12. PubMed ID: 11532714
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Octreotide therapy for chylous ascites in a chronic dialysis patient.
    Lee PH; Lin CL; Lai PC; Yang CW
    Nephrology (Carlton); 2005 Aug; 10(4):344-7. PubMed ID: 16109079
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effectiveness of the treatment of octreotide on chylous ascites after liver cirrhosis.
    Zhou DX; Zhou HB; Wang Q; Zou SS; Wang H; Hu HP
    Dig Dis Sci; 2009 Aug; 54(8):1783-8. PubMed ID: 19051030
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Successful management of congenital chylous ascites in a premature infant using somatostatin analogue.
    Huang Y; Zhuang S; Li Y; Liu M; Chen H; Du M
    Indian J Pediatr; 2011 Mar; 78(3):345-7. PubMed ID: 20953848
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Octreotide in the outpatient therapy of cirrhotic chylous ascites: a case report.
    Berzigotti A; Magalotti D; Cocci C; Angeloni L; Pironi L; Zoli M
    Dig Liver Dis; 2006 Feb; 38(2):138-42. PubMed ID: 16389001
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic management of neonatal chylous ascites: report of a case and review of the literature.
    Karagol BS; Zenciroglu A; Gokce S; Kundak AA; Ipek MS
    Acta Paediatr; 2010 Sep; 99(9):1307-10. PubMed ID: 20377539
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Medical treatment of chylous effusions in newborn infants. Apropos of 3 cases].
    Jernite M; Donato L; Favre R; Haddad J; Esposito M; Messer J
    Arch Fr Pediatr; 1992 Nov; 49(9):811-4. PubMed ID: 1300971
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Successful management of congenital chylous ascites with early octreotide and total parenteral nutrition in a newborn.
    Olivieri C; Nanni L; Masini L; Pintus C
    BMJ Case Rep; 2012 Sep; 2012():. PubMed ID: 23010459
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Successful management of chylous ascites with total parenteral nutrition and octreotide in children.
    Yang C; Zhang J; Wang S; Li CC; Kong XR; Zhao Z
    Nutr Hosp; 2013 Nov; 28(6):2124-7. PubMed ID: 24506391
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chylous ascites following radical nephrectomy: efficiency of octreotide as treatment of a ruptured thoracic duct.
    Ferrandière M; Hazouard E; Guicheteau V; Gouchet A; Bensenouci M; Lamotte C; Mercier C
    Intensive Care Med; 2000 Apr; 26(4):484-5. PubMed ID: 10872148
    [No Abstract]   [Full Text] [Related]  

  • 15. Idiopathic chylous ascites in a patient with HIV infection: response to total parenteral nutrition and octreotide therapy.
    Nunes G; Fonseca C; Barosa R; Patita M; Gomes A; Botas J; Coelho H; Brito MJ; Fonseca J
    Clin J Gastroenterol; 2018 Jun; 11(3):235-239. PubMed ID: 29427281
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chylous ascites after hepatopancreatobiliary surgery.
    Kuboki S; Shimizu H; Yoshidome H; Ohtsuka M; Kato A; Yoshitomi H; Furukawa K; Miyazaki M
    Br J Surg; 2013 Mar; 100(4):522-7. PubMed ID: 23288577
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chylous ascites after a living-donor liver graft, effectively treated in a child with octreotide.
    Ünlüsoy Aksu A; Demirtaş Z; Eğritaş Gürkan Ö; Dalgıç B; Sözen H; Dalgıç A
    Exp Clin Transplant; 2014 Mar; 12 Suppl 1():173-4. PubMed ID: 24635821
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Octreotide in congenital chylous ascites an avoid requirement of total parenteral nutrition.
    Mishra R; Kumar S
    Indian J Gastroenterol; 2007; 26(6):299-300. PubMed ID: 18431020
    [No Abstract]   [Full Text] [Related]  

  • 19. Lercanidipine-induced chyloperitoneum in patients on peritoneal dialysis.
    Yang WS; Huang JW; Chen HW; Tsai TJ; Wu KD
    Perit Dial Int; 2008; 28(6):632-6. PubMed ID: 18981394
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chyloperitoneum in Peritoneal Dialysis Secondary to Calcium Channel Blocker Use: Case Series and Literature Review.
    Piscitani L; Reboldi G; Venanzi A; Timio F; D'Ostilio A; Sirolli V; Bonomini M
    J Clin Med; 2023 Mar; 12(5):. PubMed ID: 36902718
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.